Gulrez Fazal
Boehringer Ingelheim (Canada)(CA)
Publications by Year
Research Areas
Hepatitis C virus research, HIV/AIDS drug development and treatment, Hepatitis B Virus Studies, Monoclonal and Polyclonal Antibodies Research, Chemical Synthesis and Analysis
Most-Cited Works
- → Peptide-based inhibitors of the hepatitis C virus serine protease(1998)162 cited
- → Inhibitors of Respiratory Syncytial Virus Replication Target Cotranscriptional mRNA Guanylylation by Viral RNA-Dependent RNA Polymerase(2005)129 cited
- → Discovery of Small-Molecule Inhibitors of the ATPase Activity of Human Papillomavirus E1 Helicase(2003)113 cited
- → Highly potent and selective peptide-based inhibitors of the hepatitis C virus serine protease: towards smaller inhibitors(2000)108 cited
- → Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery and preliminary SAR of benzimidazole derivatives(2003)103 cited
- → Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery of benzimidazole 5-carboxylic amide derivatives with low-nanomolar potency(2004)90 cited
- → Peptidomimetic Inhibitors of the Human Cytomegalovirus Protease(1997)85 cited
- → Studies on the C-terminal of hexapeptide inhibitors of the hepatitis C virus serine protease(1998)84 cited
- → Solid-Phase Synthesis of Peptidyl Trifluoromethyl Ketones(1999)78 cited
- → Discovery of the First Thumb Pocket 1 NS5B Polymerase Inhibitor (BILB 1941) with Demonstrated Antiviral Activity in Patients Chronically Infected with Genotype 1 Hepatitis C Virus (HCV)(2012)49 cited